McCarthy Reenie is listed as a director on 1 SEC Form D filing by 1 issuer in May 2017: InCarda Therapeutics, Inc. (Newark, CA — pharmaceuticals — 2017; $35.3M reported sold to 24 investors).
What this means One deal on file with the SEC, filed May 2017. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for McCarthy Reenie and found 5 differences, 2 worth asking the sponsor about: Bankruptcy case: Reenie Dianne Hardy and Charles Gordon Hardy; Bankruptcy case: Reenie Bruno Enterprises, Inc; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.